Show notes
In this episode, we welcome Stephanie Oestreich, Managing Director at the Multiple Myeloma Research Foundation. She holds a PhD in biochemistry from Harvard Medical School and an MPA from the Harvard Kennedy School, and has worked at the forefront of drug development at major pharma and biotech companies around the world.
Stephanie introduces the Multiple Myeloma Research Foundation and delves into the latest advances in in vivo CAR-T and cell therapy that are driving meaningful progress towards cures. With her global background, she unpacks the evolving dynamics between the U.S., European…
Website: nucleate-signal.simplecast.com

